| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |